跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,110 条关于
“follicular carcinoma”
全部
21,110
临床试验
18,897
药物
110
机构
1
资讯
2,102
去年
UK Phase III Trial Shows Low-Risk Thyroid Cancer Patients Can Safely Skip Radioiodine Ablation After Surgery
去年
Targeted Therapy and Immunotherapy Combination Shows Promise in Anaplastic Thyroid Carcinoma
去年
PD-1/PD-L1 Inhibitors Show Promise in Thyroid Cancer Treatment Through Combination Strategies
去年
Comprehensive Genomic Analysis Reveals Key Metastatic Pathways and Drug Targets in Thyroid Cancer
去年
Mosunetuzumab Shows Promise in Follicular Lymphoma, Ongoing Trials Explore Efficacy
2年前
FDA Grants Accelerated Approval to Epcoritamab for Relapsed/Refractory Follicular Lymphoma
2年前
Tafasitamab Regimen Demonstrates Improved PFS in Advanced Follicular Lymphoma
去年
FDA Approves Tafasitamab Triple Combination for Relapsed/Refractory Follicular Lymphoma
去年
Follicular Lymphoma Pipeline Shows Promise with Over 55 Therapies in Development
去年
European Commission Approves BMS's Breyanzi for Relapsed or Refractory Follicular Lymphoma
第 1 页,共 211 页
上一页
下一页